[
  {
    "column": "S2",
    "description": "S2: How old are you?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "S10",
    "description": "S10: What is the age of [pipe: S9 upper]?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "HA3",
    "description": "HA3: Number of current prescription antiseizure treatments",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "HA5",
    "description": "HA5: Number of treatments ‘never prescribed’.",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  },
  {
    "column": "B6bar1",
    "description": "B6bar1: Reducing seizure frequency - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar2",
    "description": "B6bar2: Reducing seizure severity - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar3",
    "description": "B6bar3: Reducing need for rescue medication - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar4",
    "description": "B6bar4: Manageable side effects - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar5",
    "description": "B6bar5: Improves behavior - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar6",
    "description": "B6bar6: Improves cognition - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar7",
    "description": "B6bar7: Leads to fewer hospital/Emergency Room visits - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar8",
    "description": "B6bar8: Healthcare provider recommends it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar9",
    "description": "B6bar9: Covered by insurance with affordable out-of-pocket cost - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar10",
    "description": "B6bar10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar11",
    "description": "B6bar11: Availability of support programs, such as access to a nurse hotline that can answer my questions - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar12",
    "description": "B6bar12: No cardiovascular safety concerns - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar13",
    "description": "B6bar13: Know others have had success with this treatment - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar14",
    "description": "B6bar14: Easy to comply with antiseizure treatment requirements/monitoring - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important,",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar15",
    "description": "B6bar15: Limited potential for abuse - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar16",
    "description": "B6bar16: Ability to add without having to adjust current treatments - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [p",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar17",
    "description": "B6bar17: Liquid formulation that can be used with feeding tubes - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar18",
    "description": "B6bar18: A mechanism of action that is different from an antiseizure medication we tried before - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the se",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar19",
    "description": "B6bar19: Time it takes to find out the medication is working - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Te",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "B6bar20",
    "description": "B6bar20: An antiseizure medication with minimal interactions with other current medications used - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the s",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "B6ba",
    "context": ""
  },
  {
    "column": "E5ar1",
    "description": "E5ar1: Seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar2",
    "description": "E5ar2: Long-lasting results - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar3",
    "description": "E5ar3: Time from initiation to results - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar4",
    "description": "E5ar4: Length of clinical study - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar5",
    "description": "E5ar5: Length of open-label extension - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar6",
    "description": "E5ar6: Not having to change/ make adjustments to current antiseizure treatments - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar7",
    "description": "E5ar7: Oral liquid treatment that is compatible with feeding tubes - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar8",
    "description": "E5ar8: Taken twice a day - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar9",
    "description": "E5ar9: No dietary restrictions, including being on the ketogenic diet - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E5ar10",
    "description": "E5ar10: Few/Manageable side effects - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E5a",
    "context": ""
  },
  {
    "column": "E6ar1",
    "description": "E6ar1: Not satisfied with seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar2",
    "description": "E6ar2: Not satisfied with long-term efficacy data - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar3",
    "description": "E6ar3: Clinical study is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar4",
    "description": "E6ar4: Open-label extension is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar5",
    "description": "E6ar5: Do not want an oral liquid treatment - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar6",
    "description": "E6ar6: Many side effects that seem difficult to manage - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar7",
    "description": "E6ar7: ECHO monitoring needed every 6 months - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar8",
    "description": "E6ar8: Only being available through the FINTEPLA REMS program - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar9",
    "description": "E6ar9: Potential development of heart valve problems and/or high blood pressure in the arteries of their lungs - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "E6ar10",
    "description": "E6ar10: I expect it will be expensive - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "E6a",
    "context": ""
  },
  {
    "column": "F1",
    "description": "F1: How old was [pipe: S9 upper] at the time of their [pipe: hS3] diagnosis?",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  }
]